Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 5 (2008), Issue 6 (June)

1. Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung.
   Muscle Nerve, 37(6): 786-9. [Abstract] [Full-text]
2. Variants in DNA double-strand break repair and DNA damage-response genes and susceptibility to lung and head and neck cancers.
   Int J Cancer, 123(2): 457-63. [Abstract] [Full-text]
3. Validation of a model-based segmentation approach to propagating normal anatomic regions of interest through the 10 phases of respiration.
   Int J Radiat Oncol Biol Phys, 71(3): 900-6. [Abstract] [Full-text]
4. Effects of respiration-averaged computed tomography on positron emission tomography/computed tomography quantification and its potential impact on gross tumor volume delineation.
   Int J Radiat Oncol Biol Phys, 71(3): 890-9. [Abstract] [Full-text]
5. Four-dimensional computed tomography-based interfractional reproducibility study of lung tumor intrafractional motion.
   Int J Radiat Oncol Biol Phys, 71(3): 714-24. [Abstract] [Full-text]
6. Lung adenocarcinoma: modification of the 2004 WHO mixed subtype to include the major histologic subtype suggests correlations between papillary and micropapillary adenocarcinoma subtypes, EGFR mutations and gene expression analysis.
   Am J Surg Pathol, 32(6): 810-27. [Abstract] [Full-text]
7. Interstitial lung disease in Japanese patients with lung cancer: a cohort and nested case-control study.
   Am J Respir Crit Care Med, 177(12): 1348-57. [Abstract] [Full-text]
8. Population-based phase I trial of irinotecan and epirubicin.
   Am J Clin Oncol, 31(3): 226-30. [Abstract] [Full-text]
9. Phase I dose escalation study with irinotecan, capecitabine, epirubicin, and granulocyte colony-stimulating factor support for patients with solid malignancies.
   Am J Clin Oncol, 31(3): 219-25. [Abstract] [Full-text]
10. Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer.
    Oncogene, 27(25): 3635-40. [Abstract] [Full-text]
11. First-line chemotherapy in metastatic colorectal cancer: new approaches and therapeutic algorithms. Always hit hard first?
    Curr Opin Oncol, 20(4): 459-65. [Abstract] [Full-text]
12. Cancer stem cells and the ontogeny of lung cancer.
    J Clin Oncol, 26(17): 2883-9. [Abstract] [Full-text]
13. NF-kappaB-dependent transcriptional activation in lung carcinoma cells by farnesol involves p65/RelA(Ser276) phosphorylation via the MEK-MSK1 signaling pathway.
    J Biol Chem, 283(24): 16391-9. [Abstract] [Full-text]
14. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer.
    Cancer, 112(12): 2756-64. [Abstract] [Full-text]
15. Thymidylate synthase in situ protein expression and survival in stage I nonsmall-cell lung cancer.
    Cancer, 112(12): 2765-73. [Abstract] [Full-text]
16. Final survival and safety results from a multicenter, open-label, phase 3b trial of erlotinib in patients with advanced nonsmall cell lung cancer.
    Cancer, 112(12): 2749-55. [Abstract] [Full-text]
17. The role of chemotherapy at the end of life: "when is enough, enough?".
    JAMA, 299(22): 2667-78. [Abstract] [Full-text]
18. Incidence of lung cancer among subway drivers in Stockholm.
    Am J Ind Med, 51(7): 545-7. [Abstract] [Full-text]
19. An exploration of urban and rural differences in lung cancer survival among medicare beneficiaries.
    Am J Public Health, 98(7): 1280-7. [Abstract] [Full-text]
20. BHLHB3: a candidate tumor suppressor in lung cancer.
    Oncogene, 27(26): 3761-4. [Abstract] [Full-text]
21. Manganese superoxide dismutase gene coding region polymorphisms lack clinical incidence in general population.
    DNA Cell Biol, 27(6): 321-3. [Abstract] [Full-text]
22. Lymphangioleiomyomatosis: A review.
    Eur J Intern Med, 19(5): 319-24. [Abstract] [Full-text]
23. County lung cancer mortality: a decision tree model for control and prevention.
    J Public Health Manag Pract, 14(4): E1-9. [Abstract] [Full-text]
24. Prognostic significance of BP1 mRNA expression level in patients with non-small cell lung cancer.
    Clin Biochem, 41(10): 824-30. [Abstract] [Full-text]
25. Fine-needle aspiration cytology of large cell neuroendocrine carcinoma of the lung: a cytohistologic correlation study of 11 cases.
    Cancer, 114(3): 180-6. [Abstract] [Full-text]
26. Gain of the EGFR gene located on 7p12 is a frequent and early event in squamous cell carcinoma of the lung.
    Cancer Genet Cytogenet, 184(1): 31-7. [Abstract] [Full-text]
27. Usefulness of computer-aided diagnosis schemes for vertebral fractures and lung nodules on chest radiographs.
    AJR Am J Roentgenol, 191(1): 260-5. [Abstract] [Full-text]
28. Quantitative investigation of solitary pulmonary nodules: dynamic contrast-enhanced MRI and histopathologic analysis.
    AJR Am J Roentgenol, 191(1): 252-9. [Abstract] [Full-text]
29. Incidence of melanoma and other malignancies among rheumatoid arthritis patients treated with methotrexate.
    Arthritis Rheum, 59(6): 794-9. [Abstract] [Full-text]
30. Increasing lung cancer incidence among Israeli Arab men reflects a change in the earlier paradox of low incidence and high smoking prevalence.
    Eur J Cancer Prev, 17(4): 291-6. [Abstract] [Full-text]
31. Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.
    Radiology, 248(1): 278-87. [Abstract] [Full-text]
32. Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis.
    Am J Respir Crit Care Med, 178(1): 60-73. [Abstract] [Full-text]
33. A case of *-fetoprotein-producing pulmonary carcinoma with restricted expression of hepatocyte nuclear factor-4* in hepatoid foci: a case report with studies of previous cases.
    Hum Pathol, 39(7): 1115-20. [Abstract] [Full-text]
34. Lung, liver and bone cancer mortality in Mayak workers.
    Int J Cancer, 123(4): 905-11. [Abstract] [Full-text]
35. Maximum-intensity volumes for fast contouring of lung tumors including respiratory motion in 4DCT planning.
    Int J Radiat Oncol Biol Phys, 71(4): 1245-52. [Abstract] [Full-text]
36. Effect of smoking during radiotherapy, respiratory insufficiency, and hemoglobin levels on outcome in patients irradiated for non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 71(4): 1134-42. [Abstract] [Full-text]
37. Impact of audio-coaching on the position of lung tumors.
    Int J Radiat Oncol Biol Phys, 71(4): 1118-23. [Abstract] [Full-text]
38. Analysis of carina position as surrogate marker for delivering phase-gated radiotherapy.
    Int J Radiat Oncol Biol Phys, 71(4): 1111-7. [Abstract] [Full-text]
39. Radiation dose prescription for non-small-cell lung cancer according to normal tissue dose constraints: an in silico clinical trial.
    Int J Radiat Oncol Biol Phys, 71(4): 1103-10. [Abstract] [Full-text]
40. Infrared-guided patient setup for lung cancer patients.
    Int J Radiat Oncol Biol Phys, 71(4): 1124-33. [Abstract] [Full-text]
41. Irinotecan plus cisplatin for therapy of small-cell carcinoma of the esophagus: report of 12 cases from single institution experience.
    Jpn J Clin Oncol, 38(6): 426-31. [Abstract] [Full-text]
42. Brain metastases secondary to tumor emboli from primary lung cancer during lobectomy.
    Ann Thorac Surg, 86(1): 312-3. [Abstract] [Full-text]
43. Does failed video-assisted lobectomy for lung cancer prejudice immediate and long-term outcomes?
    Ann Thorac Surg, 86(1): 235-9. [Abstract] [Full-text]
44. Persistent N2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy.
    Ann Thorac Surg, 86(1): 228-33. [Abstract] [Full-text]
45. Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina.
    Ann Thorac Surg, 86(1): 220-6; discussion 227. [Abstract] [Full-text]
46. Detection of circulating cancer cells in lung cancer patients with a panel of marker genes.
    Biochem Biophys Res Commun, 372(4): 756-60. [Abstract] [Full-text]
47. EGFR assays in lung cancer.
    Adv Anat Pathol, 15(4): 241-7. [Abstract] [Full-text]
48. C-C chemokine receptor 5 on pulmonary fibrocytes facilitates migration and promotes metastasis via matrix metalloproteinase 9.
    Am J Pathol, 173(1): 253-64. [Abstract] [Full-text]
49. Endocytosis of a single mesoporous silica nanoparticle into a human lung cancer cell observed by differential interference contrast microscopy.
    Anal Bioanal Chem, 391(6): 2119-25. [Abstract] [Full-text]
50. Bronchopulmonary neuroendocrine tumors.
    Cancer, 113(1): 5-21. [Abstract] [Full-text]
51. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
    Cancer, 113(1): 143-9. [Abstract] [Full-text]
52. Role and prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand death receptor DR5 in nonsmall-cell lung cancer and precursor lesions.
    Cancer, 113(1): 135-42. [Abstract] [Full-text]
53. Beta-carotene in multivitamins and the possible risk of lung cancer among smokers versus former smokers: a meta-analysis and evaluation of national brands.
    Cancer, 113(1): 150-7. [Abstract] [Full-text]
54. Analysis of cell cycle-related proteins in mediastinal lymph nodes of patients with N2-NSCLC obtained by EBUS-TBNA: relevance to chemotherapy response.
    Thorax, 63(7): 642-7. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.